That changed in 2025 with the publication of SURMOUNT-5, the first randomized head-to-head trial, published in the New England Journal of Medicine
This study suggests that LDN may improve quality of life, reduce pain and fatigue, and enhance immune function, indicating potential benefits for supporting healthspan in aging individuals This study highlights how NAD+ levels decline in both mouse and human Alzheimers brain samples, and how boosting NAD+ may prevent and reverse neurodegeneration and cognitive decline
We reported that in acute COVID-19, the neuropsychiatric symptoms were largely predicted by a latent factor derived from indicants of increased proinflammatory and immunoregulatory cytokines, chest computerized tomography scan abnormalities (CCTAs), including ground-glass opacities, crazy patterns and consolidation and lower oxygen saturation in peripheral blood (SpO2) [25]
(29605069) Bilirubin elevation in this range usually isnt due to acetaminophen, so other causes of liver injury should be considered
Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonzalez AM et al (2017) A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus
This is because IV therapy circumvents the potential for breakdown or dilution during the digestive process